Skip to main content

Evan Robert Myers, MD

Property title
Walter L. Thomas Professor of Obstetrics and Gynecology in the School of Medicine
Campus Mail: 244 Baker House, Durham, NC 27710
Phone: (919) 668-0296
Email: evan.myers@duke.edu

My research interests are broadly in the application of quantitative methods, especially mathematical modeling and decision analysis, to problems in women's health. Recent and current activities include integration of simulation modeling and systematic reviews to inform decisions surrounding cervical, ovarian, and breast cancer prevention and control, screening for postpartum depression, and management of uterine fibroids.    We are also engaged in exploring methods for integrating guidelines development and research prioritization.    In addition, I have ongoing collaborations using the tools of decision analysis with faculty in other clinical areas  Research is conducted through the Division of Reproductive Sciences in the Department of Obstetrics and Gynecology, the Evidence Synthesis Group in the Duke Clinical Research Institute, and the Duke Cancer Institute.  I'm also the course director for CRP 259, "Decision Sciences in Clinical Research", in Duke's Clinical Research Training Program.

Education and Training

  • Associate, Ob/Gyn, Duke University, 1992 - 1994
  • House Staff - Resident, Ob/Gyn, Duke University, 1988 - 1992
  • M.P.H., University of North Carolina at Chapel Hill, 1992
  • M.D., University of Pennsylvania, 1988

Selected Grants and Awards

Publications

Massad, LS, Einstein, M, Myers, E, Wheeler, CM, Wentzensen, N, and Solomon, D. "The impact of human papillomavirus vaccination on cervical cancer prevention efforts." Gynecol Oncol 114, no. 2 (August 2009): 360-364. (Review)

Full Text

James, AH, Myers, ER, Cook, C, and Pietrobon, R. "Complications of hysterectomy in women with von Willebrand disease." Haemophilia 15, no. 4 (July 2009): 926-931.

Full Text

Muñoz, N, Manalastas, R, Pitisuttithum, P, Tresukosol, D, Monsonego, J, Ault, K, Clavel, C, Luna, J, Myers, E, Hood, S, Bautista, O, Bryan, J, Taddeo, FJ, Esser, MT, Vuocolo, S, Haupt, RM, Barr, E, and Saah, A. "Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial." Lancet 373, no. 9679 (June 6, 2009): 1949-1957.

Full Text

Havrilesky, LJ, Maxwell, GL, and Myers, ER. "Cost-effectiveness analysis of annual screening strategies for endometrial cancer." Am J Obstet Gynecol 200, no. 6 (June 2009): 640.e1-640.e8.

Full Text

Moorman, PG, Schildkraut, JM, Iversen, ES, Myers, ER, Gradison, M, Warren-White, N, and Wang, F. "A prospective study of weight gain after premenopausal hysterectomy." J Womens Health (Larchmt) 18, no. 5 (May 2009): 699-708.

Full Text

Fish, LJ, Peterson, BL, Namenek Brouwer, RJ, Lyna, P, Oncken, CA, Swamy, GK, Myers, ER, Pletsch, PK, and Pollak, KI. "Adherence to nicotine replacement therapy among pregnant smokers." Nicotine Tob Res 11, no. 5 (May 2009): 514-518.

Full Text

Wu, JM, Siddiqui, NY, Amundsen, CL, Myers, ER, Havrilesky, LJ, and Visco, AG. "Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence." J Urol 181, no. 5 (May 2009): 2181-2186.

Full Text

Havrilesky, LJ, Broadwater, G, Davis, DM, Nolte, KC, Barnett, JC, Myers, ER, and Kulasingam, S. "Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatment." Gynecol Oncol 113, no. 2 (May 2009): 216-220.

Full Text

Brown, DR, Kjaer, SK, Sigurdsson, K, Iversen, O-E, Hernandez-Avila, M, Wheeler, CM, Perez, G, Koutsky, LA, Tay, EH, Garcia, P, Ault, KA, Garland, SM, Leodolter, S, Olsson, S-E, Tang, GWK, Ferris, DG, Paavonen, J, Steben, M, Bosch, FX, Dillner, J, Joura, EA, Kurman, RJ, Majewski, S, Muñoz, N, Myers, ER, Villa, LL, Taddeo, FJ, Roberts, C, Tadesse, A, Bryan, J, Lupinacci, LC, Giacoletti, KED, Sings, HL, James, M, Hesley, TM, and Barr, E. "The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years." J Infect Dis 199, no. 7 (April 1, 2009): 926-935.

Full Text

Wheeler, CM, Kjaer, SK, Sigurdsson, K, Iversen, O-E, Hernandez-Avila, M, Perez, G, Brown, DR, Koutsky, LA, Tay, EH, García, P, Ault, KA, Garland, SM, Leodolter, S, Olsson, S-E, Tang, GWK, Ferris, DG, Paavonen, J, Steben, M, Bosch, FX, Dillner, J, Joura, EA, Kurman, RJ, Majewski, S, Muñoz, N, Myers, ER, Villa, LL, Taddeo, FJ, Roberts, C, Tadesse, A, Bryan, J, Lupinacci, LC, Giacoletti, KED, James, M, Vuocolo, S, Hesley, TM, and Barr, E. "The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years." J Infect Dis 199, no. 7 (April 1, 2009): 936-944.

Full Text

Pages